• Janssen Launching Phase 1 Trial Testing VE202 for Potential IBD Treatment
  • Second Annual IBDHorizons Conference Will Focus on IBD Management
  • It’s Crohn’s and Colitis Awareness Week, So Let’s Talk About IBD
  • Potential IBD Therapy PTG-200 Safe, Well-tolerated in Healthy Volunteers, Phase 1 Results Show
  • Cosentyx May Increase Risk for Inflammatory Bowel Disease, Italian Researchers Say
  • My Guide to Endoscopies for Crohn’s, Part 2
  • Crohn’s and Ulcerative Colitis Prevalence in Canada — Already High — Will Almost Double by 2030, Report Warns
  • My Guide to Endoscopies for Crohn’s, Part 1
  • FDA Approves Humira Biosimilar Hyrimoz for Treatment of IBD, Other Conditions
  • Cannabis Oil Eases Symptoms of Crohn’s Disease But Not Gut Inflammation, Scientists Report
  • Antibiotic Use May Promote IBD Development by Disrupting Gut Immune Cells, Mouse Study Suggests
  • The Link Between Crohn’s Disease and a Higher Risk of Blood Clots